References
- Tomasz, M., Lipman, R., Chowdary, D., Pawlak, J., Ver-dine, G. L. and Nakanishi, K. (1987) Isolation and struc-ture of a covalent cross-link adduct between mitomycin-C and DNA. Science, 235, 1204–1208.
- Crooke, S. T. and Bradner, W. T. (1976) Mitomycin C: a review. Cancer Treat. Rev. 3, 121–139.
- Khaw, P. T., Sherwood, M. B., Mackay, S. L. D., Rossi, M. J. and Schultz, G. S. (1992) Five min treatments with fluorouracil, floxuridine, and mitomycin have long-term effects on human Tenon's capsule fibroblasts. Arch. Oph-thalmol. 110, 1150–1154.
- Occleston, N. L., Alexander, R. A., Mazure, A., Karkin, G. and Khaw, P. T. (1994) Effects of single exposures to anti-proliferative agents on ocular fibroblast-mediated collagen contraction. Invest. Ophthalmol. Vis. Sci. 35, 3681–3690.
- Chen, C. W., Huang, H. T., Bair, J. S. and Lee, C. C. (1990) Trabeculectomy with simultaneous topical applica-tion of mitomycin-C in refractory glaucoma. J. OcuL PharmacoL 6, 175–182.
- Kitazawa, Y., Kawase, K., Matsushita, H. and Minobe, M. (1991) Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch. Ophthalmol. 109, 1693–1698.
- Nuyts, R. M. M. A., Felten, P. C., Elisabeth-Pels, B. S., Langerhorst, C. T., Geijssen, H. C., Grossniklaus, H. E. and Greve, E. L. (1994) Histopathologic effects of mito-mycin-C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am.Ophthalmol. 118,225–237.
- Chen, E. P., Steinhorst, U. H., Samsa, G. P., Saloupis, P. T. and Hatchell, D. L. (1992) The effect of combined dauno-rubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy. Invest. Ophthal. Vis. Sci 33, 2160–2175.
- Wiedemann, P., Lemmen, K., Schmiedl, R. and Heimann, K. (1987) Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy. Am. I Ophthalmol. 104, 10–14.
- Kirmani, M., Santana, M., Sorgente, N., Wiedemann, P. and Ryan, S. J. (1995) Antiproliferative drugs in the treat-ment of experimental proliferative vitreoretinopathy. Ret-ina, 3, 269–272.
- Blumenkranz, M., Hernandez, E., Ophir, A. and Norton, E. W. D. (1984) 5-fluorouracil: new applications in com-plicated retinal detachment for an established antimetabo-lite. Ophthalmology, 91, 122–130.
- Steinhorst, U. H., Chen, E. P., Hatchell, D. L., Samsa, G., Saloupis, P. T., Westendorf, J. and Machemer, R. (1993) Aclacinomycin A in the treatment of experimental prolif-erative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 34, 1753–1760.
- Weller, M., Heimann, K. and Wiedemann, P. (1987) Cyto-toxic effects of daunomycin on retinal pigment epithelium in vitro. Graefe's Arch. Clin. Exp. Ophthalmol. 225, 235–238.
- Hoorn, C. M., Wagner, J. G., Petry, T. W. and Roth, R A. (1995) Toxicity of mitomycin-C toward cultured pulmo-nary artery endothelium. ToxicoL AppL PharmacoL 130, 87–94.
- Smith, S., D'Amore, P. A. and Dreyer, E. B. (1994) Com-parative toxicity of mitomycin-C and 5-fluorouracil in vitro. Am. J. Ophthalmol. 118, 332–337.
- Coomber, B. L. (1992) Influence of mitomycin-C on endo-thelial monolayer regeneration in vitro. J. Cell Biochem. 50, 293–300.
- Del Priore, L. V, Hornbeck, R., Kaplan, H. J., Jones, Z. and Swum, M. (1996) Retinal pigment epithelial debride-ment as a model for the pathogenesis and treatment of macular degeneration. Am. J. Ophthalmol. 122, 629–643.